Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC
Monday, January 20, 2020Bridge Biotherapeutics Inc a clinical stage biotech company headquartered in Seongnam Republic of Korea announced that the Investigational New Drug IND application submitted to the US Food and Drug Administration FDA has been cleared on January th
Mundipharma enters into partnership with Samsung Bioepis to expand Biosimilars to Hong Kong and Taiwan
Saturday, January 18, 2020Mundipharma today announced a partnership with Samsung Bioepis to commercialize the first biosimilar candidates from Samsung Bioepis in Taiwan and Hong KongThe partnership includes biosimilar candidates from Samsung Bioepis in the field of immunology...
Can-Fite and Univo Pharmaceuticals Collaboration Result in Discovery and Applied Patent for Cannabinoid Formulations with Broad Therapeutic Effects
Friday, January 17, 2020CanFite BioPharma Ltd a biopharmaceutical company with a pipeline of proprietary small molecule drugs that address inflammatory cancer and liver diseases today announced new findings in its collaboration with Univo Pharmaceuticals characterizing the...
International Research Collaboration Reveals Promising Drug Candidate for Treatment of Blood Cancers
Friday, January 17, 2020An international research collaboration between the United States and Australia has revealed a promising new drug that could treat highrisk leukemiaToday OncoTartis Inc and Childrens Cancer Institute jointly announced the publication of two research...
Artisan Bio Announces Global Research and Discovery Collaboration Agreement with Takeda to Develop Next-Generation Cell Therapy Products
Thursday, January 16, 2020Artisan Bio Inc a stealth cell therapy engineering company today announced it has entered into a global research and collaboration agreement with Takeda Pharmaceutical Company Limited Takeda for the discovery development and commercialization of nove...
NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration For Ulcerative Colitis
Thursday, January 16, 2020NuMedii Inc today announced a new partnership with a drug delivery company to develop new therapeutics for ulcerative colitis The collaboration will bring together NuMediis NM asset for ulcerative colitis and a proprietary delivery technology that en...
Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement
Monday, January 13, 2020Iovance Biotherapeutics Inc a latestage biotechnology company developing novel T cellbased cancer immunotherapies and Cellectis a clinicalstage biopharmaceutical company focused on developing immunotherapies based on geneedited allogeneic CAR TCells...
Zymeworks Announces Agreement with Pfizer and Initiation of a New Phase 2 Trial Evaluating ZW25 in Combination with Ibrance® (palbociclib)
Monday, January 13, 2020Zymeworks Inc a clinicalstage biopharmaceutical company developing multifunctional therapeutics today announced the initiation of a Phase trial evaluating ZW combination therapy and an agreement with Pfizer which advances the study Zymeworks HERtarg...
Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases
Friday, January 10, 2020Almirall SA and WuXi Biologics have today announced the signing of an agreement Through this collaboration Almirall embarks on its strategy to develop highly innovative biologic products for dermatology diseases including atopic dermatitis
Evotec and Bayer Announce New Alliance Focusing on Drug Discovery for Polycystic Ovary Syndrome With Novel Targets From Celmatix
Friday, January 10, 2020Evotec SE and Bayer AG today announced the expansion of their partnership in womens health indications with a new fiveyear multitarget collaboration with participation from Celmatix Inc to develop multiple clinical candidates for the treatment of pol...
